Text Size

Prediction of Visual Field Progression in Patients with Primary Open-Angle Glaucoma, Mainly Including Normal Tension Glaucoma

Nitta K., Wajima R., Tachibana G., Inoue S., Ohigashi T., Otsuka N., Kurashima H., Santo K., Hashimoto M., Shibahara H., Hirukawa M., Sugiyama K.

  • 2017
  • Scientific Reports
View publication
  • Therapeutic Area


  • Categories

    Post-Approval studies/RWE

  • Affiliations

    Fukui-ken Saiseikai Hospital, Fukui, Japan; Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; Crecon Medical Assessment Inc., Tokyo, Japan; Santen Pharmaceutical Co. Ltd., Osaka, Japan

Related Publications

Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 2-year Results from a Randomized, Multicenter Study

Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, Grover DS, Khatana AK, Lee B, Nguyen T, Stiles MC, Sadruddin O, Khaw PT.

Omidenepag Isopropyl in Latanoprost Low/Non-Responders with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3, Non-Randomized, Two-Phase, Open-Label Study

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A.

The Development of a SIBS Shunt to Treat Glaucoma

Pinchuk L.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022